Company: PTHS
Filing Date: 2025-03-27
Form Type: 10-K
Source: 0001753926-25-000503
Chunk: 1910

Company: Pelthos Therapeutics Inc.
Filing Date: 2025-03-27
Form: 10-K
Item: Item 9B
Chunk 1910
---
,111) 
    $22.68  
     — 

    Exercised 
     —  
    $—  
     — 

    Outstanding December 31, 2023 
     197,560  
    $22.68  
     9.08 

    Exercisable December 31, 2023 
     84,131  
    $22.68  
     8.98 

A
summary of the status of the Company’s nonvested options as of December 31, 2024, and 2023, and changes during years ended
December 31, 2024, and 2023, is presented below:

 Schedule
of nonvested options

    Non-vested Options 
    Options  
    Weighted- Average Exercise Price 

    Non-vested at December 31, 2023 
     113,429  
    $22.68 

    Granted 
     684,000  
    $1.26 

    Vested 
     (236,501) 
    $7.58 

    Forfeited 
     —  
    $— 

    Non-vested at December 31, 2024 
     560,928  
    $2.93 

    Non-vested Options 
    Options  
    Weighted- Average Exercise Price 

    Non-vested at December 31, 2022 
     45,556  
    $22.68 

    Granted 
     158,670  
    $22.68 

    Vested 
     (90,797) 
    $22.68 

    Forfeited 
     —  
    $— 

    Non-vested at December 31, 2023 
     113,429  
    $22.68 

The
total number of options granted during the years ended December 31, 2024 and 2023 was 684,000 and 158,670, respectively.
The exercise price for these options was $0.73, $1.30 or $22.68 per share. There was an intrinsic value of $0 and
$0 as of December 31, 2024 and 2023, respectively.

The
Company recognized stock